N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease

Sponsor: Pierre Elias • ClinicalTrials.gov ID: NCT07843004

Registry updated: 2026-09-25
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

Doctors are testing a new tool called EchoNext to see if it can help find heart problems earlier. EchoNext looks at the heart's electrical test, called an ECG, and uses artificial intelligence (AI) to check for signs of structural heart disease (SHD). SHD includes conditions like weak heart pumping, heart valve problems, or extra thickening of the heart muscle. These problems are common but often go undiagnosed until they cause serious issues like heart failure or stroke. The main questions this study will answer are: Can EchoNext alerts help emergency doctors find hidden heart problems sooner? Does this lead to more follow-up heart tests, like an echocardiogram (heart ultrasound)? What this means for patients: If a person has an ECG in the Emergency Department, the EchoNext tool may be used to check their heart. If the tool finds something unusual, their doctor may receive an alert and may then recommend further heart tests or follow-up care. This study will help researchers learn if using EchoNext improves early diagnosis and treatment of heart disease.

Interventions

  • EHR Alert (Device)
    EKG Algorithm to identify structural heart disease

Eligibility criteria

Inclusion Criteria: * 40 years of age or older * Received an ECG upon presentation to the Emergency Department Exclusion Criteria: * Had an echocardiogram within the prior 2 years. * Has a history of structural heart disease. * Not able to receive follow-up based on Community Tele-Paramedicine care manager review. * Quality of life will not improve over the next five years.

Conditions

Structural Heart Abnormality Valve Heart Disease Heart Diseases Cardiovascular Diseases

Locations

  • Columbia University Irving Medical Center / NewYork-Presbyterian — New York, New York, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record